Navigation Links
Luczo Dragon IndyCar Carries 'Eyes on the Road' Logo to Prevent Blindness to Indy 500
Date:5/20/2008

BOSTON and INDIANAPOLIS, May 20 /PRNewswire/ -- On May 25, one bright yellow IndyCar, the Number 12 Symantec Dallara Honda, will be racing to win the Indianapolis 500 bearing the symbol of a campaign to fight blindness -- Eyes on the Road. By emblazoning their car on both sides with the logo of Eyes on the Road, http://www.eyesontheroad.org, IndyCar owners Jay Penske and Steve Luczo of Luczo Dragon Racing and its driver, IndyCar Series veteran Tomas Scheckter of South Africa, add their support to a cause of great importance to all people and especially to anyone who loves to drive.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080520/NETU096 )

Eyes on the Road is the brain child of Indy 500 fan and trucking enthusiast Mark Harter of Indianapolis, who is legally blind, and consists of a partnership between Schepens Eye Research Institute in Boston and Truck.Net, the nation's leading trucking industry internet portal. Its purpose: to increase awareness of and funding for research to prevent and cure blindness.

"When we heard from Mark about the work that he and the Schepens were doing together to fight blindness, we were tremendously inspired and wanted to do what we could to help," says Jay Penske, who with partner, Steve Luczo, are already dedicated philanthropists who commit 50 percent of their winnings to charities each year.

Harter, who has idolized Penske's father Roger since childhood, reached out to the younger Penske in February with the hope that an IndyCar could be part of the Eyes on the Road initiative.

"Race car drivers are natural advocates for our mission," says Harter. "Like truckers, their ability to drive depends on great eyesight. We are thrilled that Luczo Dragon Racing agreed to bring our message to the racing community and the public."

The 32-year-old Harter, a
'/>"/>

SOURCE Schepens Eye Research Institute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Dragon Achieved Solid Increase in Sales and Profits from Continuing Operations for Q3
2. Dragon Sells EPO Business; Focus on Antibiotic Core Business
3. Chinas biotech industry: An Asian dragon is growing
4. Dragons of hope: Boat racing improves lives of breast cancer survivors
5. Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance
6. Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference
7. Obesity During Pregnancy Carries Bigger Price Tag
8. A Drug That Carries a Lower Risk of Weight Gain Than AstraZenecas Seroquel and Has Antimanic and Antidepressant Effects Would Earn a 30 Percent Patient Share in Bipolar Disorder Treatment
9. Childhood vaccination may protect adult eyes
10. Scientists Spot Eyes Motion Sensors
11. An eye for an eye: using stem cells to treat damaged eyes and a rare skin disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
... University of Liverpool had proposed that patient...t from medication.// They say that it is advisable...ptic patients. Researchers of the study feel that ...ficantly benefit the patients in having a better q...
...ccess of the World Health Day 2000 with the theme ...orld Blood Donors Day.// The date coincides with t...the ABO blood group system. The International Bl...y by the International Federation of Blood Donor O...
... analysis has been developed as a tool to diagnose...and Harvard. Researchers have also been able to de...icroRNA profile through an easy and not expensive ... small RNA molecules that control the level of pro...
...n reduce the rate of negative appendectomy by a si... imaging is also known as Computerized Axial Tomog...sectional images that may be used as a diagnostic ...iseases and health conditions. Negative appendecto...
Other Medicine News:
(Date:10/2/2008)...XFORD, England, October 2 /- Circassi...ed on the fields of allergy and critical,care, tod...cal study of its,ToleroMune(R) technology in the f...results achieved in an earlier phase II study, whi... the ToleroMune approach to allergy,desensitizatio...
(Date:10/1/2008)...AMBRIDGE, Mass., Oct. 1 /- Ironwood P... $50 million in a private equity financing.,This c...se 3 development,program evaluating linaclotide fo...onstipation (IBS-C) and chronic constipation (CC),...covered drug candidates, and to,expand commercial ...
(Date:10/1/2008)...ALIFAX, Oct. 1 / ImmunoVaccine Techno...DepoVax(TM) is showing positive,pre-clinical resul...tic,cancer and several infectious disease vaccine ...nted October 4th at the Ehrlich II conference in,G... will also be reporting,on the capabilities of IVT...
(Date:10/1/2008)...nces in diagnostics and genetic testing give women... risks, DAYTON, Ohio, Oct. 1 /- Ac...p (2007), an estimated 182,460 new cases of breast...8. And while screening,programs are resulting in t...e easily and successfully treated, breast cancer c...
Breaking Medicine Technology:Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology 2Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3 2Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3 3ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 3Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 4Study reveals surprising details of the evolution of protein translation 4435 1Study reveals surprising details of the evolution of protein translation 4435 2AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 1AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 2AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 3AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 4Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 1Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 2Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 3Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 4Temple Fox Chase and Geisinger create Keystone Institute for Translational Medicine 25344 1Temple Fox Chase and Geisinger create Keystone Institute for Translational Medicine 25344 2
...ed for continuous, random access operation, the El...rge volume laboratories that want to maximize prod...mplicity, flexibility and Stat capabilities of the...e changing needs of an aggressive laboratory testi...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t
Sample throughput of up to 80 tests per hour (4 modules). Low maintenance requirements. Continuous random access. 25 - 100 channels on board. 1008 tests or 6 hours of walkaway operation.
The Embla 96/384 well washer is a top-loading, robotic-compatible plate washer for 96- and 384-well microplate washing. It is ideal for ELISAs and most cell applications.
Medicine Products: